Search Results 1491-1500 of 41591 for oral
Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease.
The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...
Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection · More about research at Mayo Clinic.
Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.
A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors · Share · Facebook · Twitter.
For oral dosage form (tablet):. For extravascular hemolysis (EVH):. Adults—At first, 150 milligrams (mg) 3 times a day. Your doctor may adjust your dose as ...
A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.
The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...
Levamisole is used with another cancer medicine (fluorouracil) to help make it work better against cancer of the colon. Levamisole is available only with your ...
Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids; Current exposure to household contacts ≤ 15 months old or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!